Fidelity Investments’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,527
Closed -$635 5831
2024
Q2
$662 Sell
4,527
-1,656
-27% -$248 ﹤0.01% 4841
2024
Q1
$902 Sell
6,183
-315,655
-98% -$44.2K ﹤0.01% 4793
2023
Q4
$64.4K Buy
321,838
+101,342
+46% +$17.8K ﹤0.01% 3404
2023
Q3
$36.8K Buy
220,496
+199,328
+942% +$38.7K ﹤0.01% 3504
2023
Q2
$4.23K Buy
21,168
+4,774
+29% +$969 ﹤0.01% 4408
2023
Q1
$3.47K Sell
16,394
-213,215
-93% -$52.3K ﹤0.01% 4480
2022
Q4
$37.4K Buy
229,609
+228,799
+28,247% +$46.9K ﹤0.01% 3540
2022
Q3
$0 Buy
810
+310
+62% +$82 ﹤0.01% 5652
2022
Q2
$0 Sell
500
-4,605
-90% -$1.17K ﹤0.01% 5766
2022
Q1
$2K Buy
+5,105
New +$1.67K ﹤0.01% 4748
2021
Q4
Sell
-7,044
Closed -$4K 5244
2021
Q3
$4K Buy
7,044
+7,024
+35,120% +$4.14K ﹤0.01% 3884
2021
Q2
$0 Sell
20
-866
-98% -$807 ﹤0.01% 5217
2021
Q1
$1K Buy
886
+445
+101% +$727 ﹤0.01% 3926
2020
Q4
$0 Buy
+441
New +$56 ﹤0.01% 4479

Other funds holding ZOM

Fidelity Investments's ZOM Position: Q3 2024 in Review

Fidelity Investments sold out of Zomedica Corp. (ZOM) in Q3 2024, closing a stake of 4,527 shares — an estimated $635 sold.

Fidelity Investments first reported a position in ZOM in Q4 2020 and held it in 14 quarters. The position peaked at $64.4K in Q4 2023. 84 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

  • Fidelity Investments reported no remaining Zomedica Corp. position as of Q3 2024 after selling out during the quarter.
  • Fidelity Investments sold 4,527 Zomedica Corp. shares in Q3 2024, an estimated $635.
  • Fidelity Investments first reported a position in Zomedica Corp. in Q4 2020 and held it in 14 quarters.
  • Fidelity Investments's Zomedica Corp. position peaked at $64.4K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on Fidelity Investments's 13F filing for Q3 2024, filed 13 Nov 2024.